NYSE Euronext saw global derivatives average daily volume (“ADV”) of 8.8 million contracts traded per day in April 2011 a decrease of 18.5% versus the prior year, which benefited from un-seasonally strong trading volumes due to heightened market volatility driven by the sovereign debt crisis in Europe.
April 2010 was the second highest level of derivatives monthly trading volume in 2010, second only to May 2010. When compared to the strong first quarter of 2011, Global Derivatives trading volumes in April 2011 are down only 2.4%. Cash equities ADV in April 2011 declined across all venues, with European cash ADV decreasing 3.9% and U.S. cash trading volumes decreasing 30.8% from April 2010 levels.
NYSE Euronext European derivatives products ADV in April 2011 was 4.7 million futures and options contracts, a decrease of 30.5% from April 2010 and a decrease of 1.0% from March 2011.
The 4.7 million in European derivatives futures and options contracts ADV in April 2011 consisted of 2.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.8 million contracts, or 39.0%, executed through Bclear, NYSE Liffe’s trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 26.9% compared to April 2010 and decreased 26.4% from March 2011.
Year-to-date, European derivatives products ADV of 4.7 million contracts was 12.5% below prior year levels. The 4.7 million in futures and options contracts ADV year-to-date consisted of 3.6 million contracts executed through LIFFE CONNECT trading platform and 1.0 million contracts, or 21.8%, executed through Bclear.
Total fixed income products ADV of 1.9 million contracts in April 2011 decreased 29.9% from April 2010 and decreased 27.8% from March 2011. Year-to-date, total fixed income products ADV of 2.5 million contracts was 7.3% below prior year levels
Total equity products (including Bclear) ADV of 2.7 million contracts in April 2011 decreased 31.8% compared to April 2010, but increased 35.9% from March 2011. The 2.7 million contracts in equity products ADV consisted of 2.3 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 2.3 million contracts in individual equity products ADV consisted of 1.8 million in futures contracts, which represented a 32.1% decrease compared to April 2010 and 0.5 million in options contracts, which represented a 37.6% decrease compared to April 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.0 million contracts was 19.6% below prior year levels.
Total commodities products ADV of 77,000 contracts in April 2011 increased 34.7% compared to April 2010 and decreased 23.6% compared to March 2011. Year-to-date, total commodities product ADV of 86,000 contracts was 60.5% above prior year levels.
NYSE Euronext US equity options (NYSE Arca and NYSE Amex) ADV of 4.0 million contracts in April 2011 decreased 0.3% compared to April 2010 and decreased 7.6% compared to March 2011. Year-to-date, U.S. equity options ADV of 4.3 million contracts was 13.7% above prior year levels.
Total US consolidated equity options ADV decreased 1.5% to 15.7 million contracts in April 2011 compared to April 2010 and decreased 6.5% compared to March 2011. Year-to-date, US consolidated equity options ADV of 16.9 million contracts was 16.8% above prior year levels.
NYSE Euronext’s US options exchanges accounted for 25.7% of the total US consolidated equity options trading in April 2011, up from 25.4% in April 2010 and down from 26.0% in March 2011.
NYSE Euronext US futures and futures options (NYSE Liffe US) ADV in April 2011 was approximately 91,700 contracts, compared to 18,800 contracts in April 2010.
Year-to-date, US futures and futures options ADV of 38,800 contracts was 91.3% above prior year levels.
